4. DETERMINATION OF DOSE AND DOSING INTERVALS

Determination of Dose and Dosing Intervals

Designing an effective dosage regimen is one of the most important applications of clinical pharmacokinetics. The goal is to ensure that drug concentrations stay within the therapeutic window—high enough to produce the desired effect but low enough to avoid toxicity. Determining the correct dose and dosing interval requires understanding the pharmacokinetic parameters of the drug, as well as patient-specific factors such as organ function, age, weight, and disease state.


Objectives of Dosage Regimen Design

A dosage regimen aims to achieve:

  • Therapeutic drug concentrations
  • Minimal toxicity
  • Consistent plasma levels (steady state)
  • Individualized treatment for each patient

Two core components of a dosage regimen are the dose and the dosing interval (τ). Both depend on how the body handles the drug through absorption, distribution, metabolism, and excretion.


Loading Dose (LD)

A loading dose is administered to achieve therapeutic concentrations rapidly, especially for drugs with a long half-life.

Purpose:

  • Quickly reach therapeutic levels
  • Useful in emergencies or severe infections

The loading dose depends primarily on the volume of distribution (Vd) and the desired plasma concentration (Ctarget).

Formula:

LD = (Vd × Ctarget) / F

Where F = bioavailability. For IV administration, F = 1.


Maintenance Dose (MD)

The maintenance dose maintains steady-state drug concentration over long-term therapy.

Purpose:

  • Keep plasma concentration within the therapeutic range
  • Compensate for drug elimination

The maintenance dose depends on clearance (Cl), dosing interval (τ), and desired steady-state concentration (Css).

Formula:

MD = (Cl × Css × τ) / F

This formula ensures that the amount of drug given equals the amount eliminated per dosing interval.


Determination of Dosing Intervals (τ)

The dosing interval determines how often the medication should be administered. It is strongly influenced by the drug’s half-life (t1/2) and therapeutic window.

Factors influencing dosing interval:

  • Half-life: Longer half-life → longer dosing intervals
  • Therapeutic index: Narrow therapeutic index → shorter intervals to avoid peaks and troughs
  • Patient compliance: Once-daily dosing preferred when safe
  • Drug effect duration: Pharmacodynamic properties also influence interval

Steady State Concentration (Css)

Steady state occurs when the amount of drug administered equals the amount eliminated during each dosing interval. It typically requires 4–5 half-lives to reach steady state.

Importance:

  • Allows predictable drug levels
  • Prevents accumulation toxicity
  • Guides therapeutic drug monitoring (TDM)

Accumulation of Drug

Repeated drug dosing leads to accumulation until steady state is achieved. The degree of accumulation depends on the dosing interval relative to the half-life.

Accumulation Ratio (R):

R = 1 / (1 − e−kτ)

Where k = elimination rate constant.


Peak and Trough Concentrations

Two critical concentration points in multiple dosing regimens are:

  • Peak concentration (Cmax): highest concentration after a dose
  • Trough concentration (Cmin): lowest concentration before the next dose

Maintaining Cmax below toxic levels and Cmin above minimum effective concentration ensures therapeutic activity.


Relationship Between Dose, Interval, and Plasma Concentration

Three major methods help control plasma drug concentration:

1. Adjust the Dose

Higher dose → higher steady-state concentration.

2. Adjust the Dosing Interval

Shorter intervals → reduced fluctuation between peak and trough.

3. Adjust Both

Used for drugs with narrow therapeutic ranges.


Pharmacokinetic Parameters Affecting Dose and Interval

1. Clearance (Cl)

Higher clearance → higher dose required.

2. Volume of Distribution (Vd)

Larger Vd → larger loading dose needed.

3. Half-Life (t1/2)

Determines dosing interval.

4. Bioavailability (F)

Affects both loading and maintenance doses.


Practical Considerations in Clinical Dose Determination

Renal Impairment

Reduced clearance requires lower dose or longer dosing intervals.

Hepatic Impairment

Adjust dose for drugs with significant hepatic metabolism.

Age

  • Elderly → decreased clearance
  • Pediatrics → variable metabolism

Obesity

Dosing based on ideal, actual, or adjusted body weight depending on the drug’s Vd.


Dosing Regimen Examples

1. Antibiotics

Frequent dosing required for concentration-dependent or time-dependent killing.

2. Antiepileptics

Narrow therapeutic window → requires precise dose and interval.

3. Cardiovascular Drugs

Steady-state maintenance is critical to avoid toxicity.

Detailed Notes:

For PDF style full-color notes, open the complete study material below:

PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL PHARMACOKINETICS AND PHARMACOTHERAPEUTIC DRUG MONITORING (TDM)/ DETERMINATION OF DOSE AND DOSING INTERVALS.

Share your love